Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Dehko 2D Project (D2D) Implementation Project of the Programme for the Prevention of Type.

Slides:

Advertisements

Similar presentations

Chapter 38 Stewart B. Harris, Onil Bhattacharyya,

Advertisements

National Service Frameworks Dr Stephen Newell February 2002.

National Service Framework for diabetes Ruth BarnesMina Fernando Director of Public HealthDiabetes Manager.

1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.

Jolene Johnson, MD Associate Clinical Professor of Medicine, LSU School of Medicine Head, Statewide Diabetes Disease Management, LSU HCSD Diabetes Disease.

Commissioning for Value 24 th March 2015 Dr Stephen Liversedge NHS Bolton CCG.

Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:

Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.

Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.

Diabetes Mellitus Type 2

Cervical cancer screening problems and barriers in Latvia

WHAT IS ‘HEALTH PROMOTION’ ? WHAT IS ‘HEALTH PROMOTION’ ?

NATIONAL AND COMMUNITY MENTAL HEALTH PROGRAMME. AIMS OF NCMHP To ensure treatment and prevention of mental and neurological disorder. To ensure treatment.

PROTOCOL OF COMMUNITY BASED YOGIC LIFESTYLE INTERVENTION: A NATIONAL STRATEGY FOR PREVENTION AND EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES AMONG ELDERLY.

What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.

Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.

1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.

Prediabetes Burden.

MSc in Diabetes A population approach Ross Lawrenson Postgraduate Medical School University of Surrey Impaired glucose tolerance and undiagnosed diabetes.

EPIDEMIOLOGY Epidemiology of chronic kidney injury, including prevalence and prognosis in various community groups. Screening of populations for kidney.

HSB examples from Finland Nea Malila Mass Screening Registry, Cancer Society of Finland and University of Tampere, Tampere School of Public Health.

Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.

Designing Screening Protocols for Diabetes and Pre-diabetes Ron Horswell, PhD (PBRC) Gang Hu, MD PhD (PBRC) Study group: Jolene Johnson, MD (LSU HSC) Will.

Health & Welfare Council of Long Island May 12, 2010.

FINDRISC IN SWEDEN The feasibility of the questionnaire in a Swedish population 1,2,3 M.I. Hellgren, 3 P. Friberg, 4 M. Petzold, 1 C. Björkelund, 4 H.

Umpqua Health Alliance Umpqua Community Health Center Extended Care Clinic Integrated clinic for patients with complex health and addiction issues.

FY 2008 – 2009 AGREEMENT ADDENDA 536 and 541 CHANGES.

Employee health and wellness metrics, measurements, and evaluation - - the building blocks for ROI David A. Alter, M.D., Ph.D., F.R.C.P.C Senior Scientist,

GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.

Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.

Intermountain Diabetes Prevention Program : Stepping Back to Move Forward Elizabeth Joy, MD, MPH Medical Director, Clinical Outcomes Research Family Medicine.

Detecting Diabetes Tools for better care. Diabetes in New Zealand people with diabetes – type 2, type 1 Ethnic differences –European.

Pre-diabetes: Risk Factors & Diagnosis Saoirse Ní Chuirrín DNS Caitriona Lordan Dietitian September 2015.

Long Term Conditions Strategy There are 3 key aims to our improvement strategy: WHCCG has already achieved: – Commissioned Diabetes education through the.

This presentation is the intellectual property of the authors. Contact for permission to reprint and/or This.

Expanded focus on Long-term Conditions (including the new Diabetes plan) 2016/17 National Planning workshop 13 Nov 2015.

1 The Costs of Diabetes in Europe Don’t Lose Sight of the Costs Rhys Williams Prifysgol Cymru Abertawe (University of Wales Swansea, UK)

STarT Back Screening Tool (SBST) General Presentation.

Experiences of Pay for Performance in the Danish Health Care Sector Pay for Performance. Perspectives Around the Globe Annual Research Meeting 2006, Seattle.

Development Programme for the Prevention and Care of Diabetes, DEHKO Leena Etu-Seppälä Finnish Diabetes Association.

Population Primary Prevention Interventions for Vascular Disease How can we make more progress?

Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.

NCB Noël Barengo, MD, PhD, MPH Department of Public Health University of Helsinki, Finland Unit of Clinical Research, University Hospital La Paz,

Sometimes you have to be the worst to become the best?  2006: My Region was highlighted as having significantly high admissions for diabetes.  Our performance.

Pre Diabetes Paul Westcar GP/Diabetes Lead Newbury and District CCG.

Promoting Global Health thru Service and Research in a Kuzmolovsky, Russia Healthcare Clinic Ellen Jones, ND, APRN-BC Louise Ivanov, PhD, RN Debra C. Wallace,

Thames Valley SCN Diabetes Reference Group The NHS Diabetes Prevention Programme Professor Jonathan Valabhji National Clinical Director.

Measures of Hyperglycemia Random plasma glucose (RPG)—without regard to time of last meal Fasting plasma glucose (FPG)—before breakfast Oral glucose tolerance.

A Risk Assessment Tool for Undetected Hyperglycemia Richelle J. Koopman, MD, MS** Arch G. Mainous III, PhD* Arch G. Mainous III, PhD* Charles J. Everett,

Rebecca K Simmons, Justin B Echouff o-Tcheugui, Stephen J Sharp, Lincoln A Sargeant, Kate M Williams, A Toby Prevost, Ann Louise Kinmonth, Nicholas J Wareham,

Screening System for Hypertension and Diabetes at Primary Care Level

Now let’s see some REGIONAL STATS Regional Facts Island Gate © 2014.

Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.

Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.

IDF DIABETES ATLAS Eighth edition 2017.

Goals Boosting Diabetes and Pre-Diabetes Screening

PREVALENCE OF HIGH RISK FOR TYPE2 DIABETES IN CENTRAL SPAIN

National Diabetes Strategy Updates Dr. Al Anoud Mohammed Al-Thani

AGES HEALTH Le Thi Kim Thoa MD, MPH Faculty of Public Health

The prevalence of diabetes (A), impaired glucose tolerance (B), impaired fasting glucose (C), and impaired glucose metabolism (D) among those with Finnish.

Training for Practice Nurses and Health Care Assistants on EARLY PRESENTATION OF CANCER Trainer Notes: This course has been written by Dr C Hunt (GP Primary.

Prediabetes Burden.

Evaluating the cost-effectiveness of interventions with an impact on ageing P. Breeze, P. Thokala, L. Lafortune, C. Brayne, A. Brennan 07/12/2018.

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Presentation of the new IDF DIABETES ATLAS WORLD DIABETES DAY.

IDF DIABETES ATLAS Eighth edition 2017.

Schematic depiction of three stages of the natural history of T2D, noting several opportunities for improvement of management. Schematic depiction of three.

Presentation transcript:

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Dehko 2D Project (D2D) Implementation Project of the Programme for the Prevention of Type 2 Diabetes Liisa Hiltunen MD, vice president Marjatta Stenius-Kaukonen vice president Finnish Diabetes Association

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association The five geographical areas of FIN-D2D North Ostrobothnia -population South Ostrobothnia -population Central Finland -population Pirkanmaa -population North Savonia -population

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Implementation Project of the Programme for the Prevention of Type 2 Diabetes The action plan Dehko 2D Project (D2D)

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association FIN-D2D Programme, AIMS 1.To reduce the incidence of type 2 diabetes and to reduce risk factors and care requirements for the complications of type 2 diabetes 2.To identify among the population those who are at high risk of developing type 2 diabetes 3.To provide earlier diagnosis when people are unaware of their type 2 diabetes 4.To bring people with type 2 diabetes quickly into the sphere of appropriate treatment 5.To generate regional and local models and programmes for the prevention of type 2 diabetes 6.To demonstrate the cost-effectiveness of prevention

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Programme for the Prevention of Type 2 Diabetes in Finland Three Strategies Population Strategy High-Risk Strategy Strategy of Early Diagnosis and Management

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association

Screening, diagnosis and interventions in FIN-D2D CHD Gestational diabetes IFG, IGT Score <7 Score 7-14Written information No preventive measures Score ≥15 OGTT Normoglycemia IFG IGT Diabetes Interventions Follow-up FINDRISC Treatment of hyperglycemia and risk factors Evaluation

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association D2D Project: Intervention Identification of high-risk subject 1. Visit (nurse) 2. Visit (doctor) Group intervention Individual intervention Self-initiated lifestyle changes Other Intervention forms Yearly follow-ups Primary health care or other players: Weight control groupsQuit smoking-groupsExercise groupsSelf-activity groups Regular healthcare visits

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association Evaluation of the FIN-D2D The feasibility, effectiveness and costs of the FIN-D2D will be evaluated according to a spesific evaluation plan Evaluation includes comparison of five geographical areas of FIN-D2D to the rest of Finland regarding for example incidence of T2D and prevalence of undiagnosed T2D

Dehko 2D Project (D2D) 2003–2007 Finnish Diabetes Association